Apollomics, Inc. (NASDAQ:APLMW) Sees Large Increase in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 65,000 shares, a growth of 10.4% from the September 30th total of 58,900 shares. Based on an average daily volume of 19,000 shares, the short-interest ratio is presently 3.4 days.

Apollomics Stock Performance

Shares of APLMW stock opened at $0.01 on Thursday. Apollomics has a 12 month low of $0.01 and a 12 month high of $0.06. The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.01.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.